Skip to content
Feral Cat LogoGovInfoNow
FDA drug shortage status

Is Tazemetostat Hydrobromide Tablet (Tazverik) in shortage?

Tazemetostat Hydrobromide Tablet is listed by FDA as being discontinued by at least one maker (updated Mar 27, 2026).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Tazverik, Tablet, 200 mg (NDC 72607-100-00)
    Epizyme, Inc. (An Ipsen Company)Being discontinuedUpdated Mar 27, 2026Discontinued Mar 27, 2026

    Discontinuation of the manufacture of the drug product

    Maker contact: (855)-463-5127

Tazemetostat Hydrobromide Tablet shortage questions

Is Tazemetostat Hydrobromide Tablet (Tazverik) in shortage?

Tazemetostat Hydrobromide Tablet is listed by FDA as being discontinued by at least one maker (updated Mar 27, 2026).

What should I do if I can’t get Tazemetostat Hydrobromide Tablet?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.